Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Gachon University Gil Medical Center |
---|---|
Information provided by: | Gachon University Gil Medical Center |
ClinicalTrials.gov Identifier: | NCT00745407 |
Fenofibrate increases adiponectin levels, but reduces leptin levels
Condition | Intervention | Phase |
---|---|---|
Hypertriglyceridemia |
Drug: fenofibrate |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Crossover Assignment |
Study Start Date: | January 2005 |
Study Completion Date: | August 2008 |
Arms | Assigned Interventions |
---|---|
fenofibrate 160 mg, placebo: Experimental | Drug: fenofibrate |
Ages Eligible for Study: | 25 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | GMC 200511 |
Study First Received: | September 2, 2008 |
Last Updated: | September 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00745407 History of Changes |
Health Authority: | South Korea: Institutional Review Board |
adipocytokines insulin sensitivity hypertriglyceridemic patients |
Antimetabolites Metabolic Diseases Hyperlipidemias Hypertriglyceridemia Antilipemic Agents |
Procetofen Metabolic Disorder Insulin Dyslipidemias Lipid Metabolism Disorders |
Antimetabolites Metabolic Diseases Hyperlipidemias Hypertriglyceridemia Molecular Mechanisms of Pharmacological Action Therapeutic Uses |
Antilipemic Agents Procetofen Pharmacologic Actions Dyslipidemias Lipid Metabolism Disorders |